INOVIQ Ltd news

INOVIQ (ASX:IIQ) is developing and commercialising next-generation exosome capture tools and precision diagnostics in what CEO Dr Leearne Hinch says is a $15bn medical diagnostics market opportunity for some of the most common – and deadly - cancers.

“There’s a clear unmet need for earlier and more accurate cancer diagnostics and INOVIQ is de